Filing Details
- Accession Number:
- 0001562180-20-003588
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-13 18:29:12
- Reporting Period:
- 2020-05-11
- Accepted Time:
- 2020-05-13 18:29:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1434418 | Constellation Pharmaceuticals Inc | CNST | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1246842 | A Mark Goldsmith | C/O Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200 Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-11 | 100 | $1.55 | 143,163 | No | 4 | M | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
Common Stock | Disposition | 2020-05-11 | 100 | $50.00 | 143,063 | No | 4 | S | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
Common Stock | Acquisiton | 2020-05-12 | 2,625 | $1.55 | 145,688 | No | 4 | M | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
Common Stock | Acquisiton | 2020-05-12 | 300 | $11.50 | 145,988 | No | 4 | M | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
Common Stock | Acquisiton | 2020-05-12 | 1,300 | $7.60 | 147,288 | No | 4 | M | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
Common Stock | Disposition | 2020-05-12 | 4,225 | $50.05 | 143,063 | No | 4 | S | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
No | 4 | S | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
No | 4 | M | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
No | 4 | M | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
No | 4 | M | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
No | 4 | S | Indirect | Owned by Trusts for which Mark A. Goldsmith is a Trustee |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2020-05-11 | 100 | $0.00 | 100 | $1.55 |
Common Stock | Stock Option (right to buy) | Disposition | 2020-05-12 | 2,625 | $0.00 | 2,625 | $1.55 |
Common Stock | Stock Option (right to buy) | Disposition | 2020-05-12 | 300 | $0.00 | 300 | $11.50 |
Common Stock | Stock Option (right to buy) | Disposition | 2020-05-12 | 1,300 | $0.00 | 1,300 | $7.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,612 | 2021-03-10 | No | 4 | M | Direct | |
14,987 | 2021-03-10 | No | 4 | M | Direct | |
6,825 | 2028-07-18 | No | 4 | M | Direct | |
12,446 | 2028-03-07 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $50.00 to $50.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares are fully vested.
- This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 19, 2021.
- This option was granted on March 8, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through March 8, 2021.